Bloomberg
Future Vaccines Have 'High Barrier' to Cross, Vir CEO Says
Dec.04 -- Vir Biotechnology Inc. Chief Executive Officer George Scangos says the manufacturing of vaccines is a highly regulated, complex process and the capacity to make drugs for Covid-19 is "somewhat limited." He speaks on "Bloomberg...
Bloomberg
Sputnik V Is Great Vaccine, Will Save Lots of Lives: RDIF CEO
Dec.29 -- Kirill Dmitriev, the chief executive officer of the Russian Direct Investment Fund (RDIF), discusses the plan to deliver 10 million doses of the Sputnik V Covid-19 vaccine to Argentina. RDIF signed an agreement with AstraZeneca...
Curated Video
Novavax's Potential Coronavirus Vaccine Moves To Phase 2 Trials
The company said Monday this phase will determine if it can safely protect against the virus.
Bloomberg
Wuxi Biologics: Covid-19 Antibody Products Out By Year End
Aug.18 -- Chris Chen, chief executive officer at Wuxi Biologics Cayman Inc., discusses first-half earnings, the progress they’re making on Covid-19 treatments and the company’s expansion plans. He speaks exclusively on “Bloomberg...
Curated Video
Newsy's Latest Health News
U.S. reaches $1.5 billion vaccine deal with Moderna. Researchers say young people who smoke or use e-cigarettes are more likely to get COVID-19.
Curated Video
Human trial for COVID-19 vaccine underway in UK
The chief investigator of a UK COVID-19 vaccine trial has outlined plans to fast track the next phase of the study, as human testing got underway on Thursday.
Bloomberg
Bharat Biotech's Coronavirus Vaccine Gets a Nod from Indian Regulator
Jan.03 -- India's regulator has given a nod to the locally-developed the coronavirus vaccine by Bharat Biotech for "restricted use in emergency situation" while the shot developed by AstraZeneca Plc and the University of Oxford was...
Bloomberg
World Bank's Malpass on Vaccine Distribution, Debt Relief
Apr.07 -- World Bank President David Malpass discusses the distribution of Covid-19 vaccines in developing nations and says finance ministers from the Group of 20 nations are supportive of extending debt relief for the world’s poorest...
Bloomberg
Hong Kong Facing a Lot of Vaccine Hesitancy: Professor
Mar.30 -- Benjamin Cowling, professor of infectious disease epidemiology at the School of Public Health of Hong Kong University, discusses the Covid-19 vaccination rollout in the city and the hesitancy to take the shot. Hong Kong’s...
Bloomberg
Swiss Re Adds $900 Million to Reserves
Feb.19 -- John Dacey, chief financial officer at Swiss Re AG, discusses his outlook for pandemic-related claims in 2021, exposure to vaccine rollout and how climate change impacts his business. He speaks on “Bloomberg Markets: European...
Bloomberg
SARB Has Scope to Respond to Third Virus Wave, Kganyago Says
Jan.28 -- South African Reserve Bank Governor Lesetja Kganyago says the central bank will assess the impact on economic activity should there be a third wave of coronavirus infections. He speaks on "Bloomberg Markets."
Bloomberg
Italy’s Letta on EU Recovery Fund, EU-U.S. Relations
Nov.11 -- Former Italian Prime Minister Enrico Letta discusses Italy’s stimulus needs, if the $750 billion recovery fund will be enough and the EU-U.S. relationship. He speaks on “Bloomberg Daybreak: Europe.”
Curated Video
Eligible People Still Struggling To Get COVID-19 Vaccine
Vaccine eligibility is expanding to more and more people, but that doesn't necessarily mean they'll be able to get a shot easily.
Bloomberg
Fed's Efforts to Hold Down Rates Raises Inflationary Pressures: Dalio
Mar.19 -- Bridgewater Co-Chairman and Co-CIO Ray Dalio says that the Fed's monetization efforts to hold down rates raises inflationary pressures. He says that in the current environment, "cash is trash." He joins David Westin exclusively...
Bloomberg
Fitch Grades U.A.E. at AA- in First Rating
Nov.12 -- Jan Friedrich, senior director and head of MEA sovereigns at Fitch Ratings, discusses the rating for the U.A.E. and the reasons behind the grade. He speaks on “Bloomberg Daybreak: Middle East.”
Bloomberg
More to Fear From Microbes Than From Xi Jinping: Summers
Apr.16 -- Former U.S. Treasury Secretary Lawrence H. Summers, a Wall Street Week contributor, says that the U.S. And the rest of the developed world has a responsibility to help low and middle-income countries recover from the pandemic,...
Bloomberg
FDA Advisers Back Moderna's Covid-19 Vaccine
Dec.17 -- Moderna Inc.'s Covid-19 vaccine wins backing from a panel of experts who advise U.S. regulators. Food and Drug Administration advisers voted 20 to 0, with one abstention, on Thursday that the benefits of the vaccine outweigh...
Bloomberg
Moderna Says New Vaccine Protects Against Two Covid Strains
Jan.25 -- Moderna Inc. said its vaccine will protect against two known variants of the Covid-19 vaccine, but it plans to start human studies of a booster shot for a strain from South Africa that may cause immunity to wane more quickly....
Bloomberg
Johns Hopkins' Message on Delta Variant: Get Vaccinated
Jun.29 -- Dr. Amesh Adalja, Johns Hopkins Center for Health Security senior scholar, says the delta variant shows how important it is to get vaccinated. The Johns Hopkins Bloomberg School of Public Health is supported by Michael R....
Bloomberg
Save Big Holiday Parties for Next Year, Epidemiologist Says
Dec.07 -- University of California San Francisco Professor of Epidemiology Dr. George Rutherford discuses California lockdowns, the acceleration of cases after Thanksgiving, and Covid-19 vaccine distribution. He speaks on "Bloomberg...
Curated Video
State, Local Officials Prepare To Distribute COVID-19 Vaccines
State and local health officials plead for more federal funds and information as they get ready to distribute the first COVID-19 vaccine doses.
Bloomberg
Deaths Top 1 Million as Countries Lose Control of Virus: UCL
Sep.29 -- University College London Principal Research Fellow Jennifer Rohn discusses rising covid-19 infection rates, expectations for the virus in the colder weather, and experiments with guidelines to control the coronavirus. She...
Bloomberg
Moderna Wants to Develop One Shot for Flu and Covid-19
Jan.25 -- Moderna Chief Executive Officer Stephane Bancel says Covid-19 is not going away. He says the company wants to develop a shot that can protect you from the flu and Covid-19. He speaks on "Bloomberg Markets."
Bloomberg
Coronavirus Treatment: Antibodies and the Race for a Vaccine
May.04 -- Takeda President of Global Business Rajeev Venkayya discusses efforts among companies and nations to develop a coronavirus vaccine and the importance of making the vaccine available to the entire world. He speaks on "Bloomberg...